ホーム>>Lipids>> Endocannabinoid/Endocannabinoid-like>>(R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide

(R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide

カタログ番号GC41709

N-アシルエタノールアミン(NAE)には、関連するアシル基に強く影響を受ける多様な生物学的作用があります。

Products are for research use only. Not for human use. We do not sell to patients.

(R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide 化学構造

Cas No.: 1282618-08-9

サイズ 価格 在庫数 個数
1mg
$111.00
在庫あり
5mg
$502.00
在庫あり
10mg
$891.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. Docosahexaenoyl ethanolamide (DHEA) has potential signaling roles in cancer, inflammation, and neurological development and functioning. At least some of DHEA's effects are mediated through cannabinoid (CB) receptors, while some NAEs also act as vanilloid receptor agonists and voltage-gated K+ channel blockers. (R)-(+)-Docosahexaenyl-1'-hydroxy-2'-propylamide is a homolog of DHEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen. A similar modification of arachidonoyl ethanolamide to produce R-1 methanandamide imparts higher affinity for the CB receptor as well as improved metabolic stability. The physiological actions of this compound have not been evaluated.

レビュー

Review for (R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.